NRG
TGTX icon

Nemes Rush Group’s TG Therapeutics TGTX Stock Holding History

Nemes Rush Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.1K Hold
2,019
– – 0.01% 313
2025
Q4 		$60.2K Hold
2,019
– – 0.01% 324
2025
Q3 		$72.9K Hold
2,019
– – 0.01% 284
2025
Q2 		$72.7K Hold
2,019
– – 0.01% 279
2025
Q1 		$79.6K Buy
2,019
+19
+1% +$639 0.01% 273
2024
Q4 		$60.2K Hold
2,000
– – 0.01% 284
2024
Q3 		$30.4K Hold
2,000
– – ﹤0.01% 310
2024
Q2 		$35.6K Hold
2,000
– – ﹤0.01% 294
2024
Q1 		$30.4K Hold
2,000
– – ﹤0.01% 337
2023
Q4 		$34.2K Hold
2,000
– – 0.01% 304
2023
Q3 		$16.7K Hold
2,000
– – ﹤0.01% 352
2023
Q2 		$49.7K Buy
+2,000
New +$51.7K 0.01% 264

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return